These medications include semaglutide (marketed as Ozempic for diabetes and Wegovy for weight management), liraglutide (Victoza for diabetes and Saxenda for weight management), dulaglutide (Trulicity for diabetes), and tirzepatide (Mounjaro for diabetes), which combines GLP-1 action with glucose-dependent insulinotropic polypeptide (GIP) receptor agonism
Overall, while BPC 157 shows potential benefits in tissue repair, the lack of human clinical data necessitates cautious and informed use
The LeanMD team helps patients navigate insurance and prior authorization
This is the peptide that came to be known as PT-141
During periods of semaglutide use, the reduction was 42% compared with periods when GLP-1 medications were not used
Since researchers used data from Medicare administrative claims, it is possible that they missed some health information or that there was misclassification, such as misclassification of depression cases